Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, 56126 Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Int J Mol Sci. 2017 Nov 3;18(11):2321. doi: 10.3390/ijms18112321.
This review describes recent advances in the comprehension of signaling pathways involved in breast cancer progression. Calcium sensing receptor (CaSR), caveolae signaling, signaling referred to hypoxia-inducing factors and disturbances in the apoptotic machinery are related to more general biological mechanisms and are considered first. The others refer to signaling pathways of more specific biological mechanisms, namely the heparin/heparin-sulfate interactome, over-expression of miRNA-378a-5p, restriction of luminal and basal epithelial cells, fatty-acid synthesis, molecular pathways related to epithelial to mesenchimal transition (EMT), HER-2/neu gene amplification and protein expression, and the expression of other members of the epithelial growth factor receptor family. This progress in basic research is fundamental to foster the ongoing efforts that use the new genotyping technologies, and aim at defining new prognostic and predictive biomarkers for a better personalized management of breast cancer disease.
本文综述了近年来对乳腺癌进展相关信号通路的理解所取得的进展。钙敏感受体(CaSR)、小窝信号、缺氧诱导因子信号和细胞凋亡机制的紊乱与更普遍的生物学机制有关,被认为是首要的。其他信号通路与更具体的生物学机制有关,即肝素/硫酸乙酰肝素相互作用体、miRNA-378a-5p 的过度表达、限制腔上皮细胞和基底上皮细胞、脂肪酸合成、与上皮间质转化(EMT)相关的分子通路、HER-2/neu 基因扩增和蛋白表达,以及上皮生长因子受体家族其他成员的表达。这一基础研究的进展对于推动利用新的基因分型技术的持续努力至关重要,旨在为乳腺癌疾病的更好个性化管理定义新的预后和预测生物标志物。